AMIKIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amikin, and when can generic versions of Amikin launch?
Amikin is a drug marketed by Apothecon and is included in four NDAs.
The generic ingredient in AMIKIN is amikacin sulfate. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amikin
A generic version of AMIKIN was approved as amikacin sulfate by MEITHEAL on September 28th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMIKIN?
- What are the global sales for AMIKIN?
- What is Average Wholesale Price for AMIKIN?
Summary for AMIKIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,166 |
| DailyMed Link: | AMIKIN at DailyMed |
Recent Clinical Trials for AMIKIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Raja Isteri Pengiran Anak Saleha Hospital | N/A |
| Thammasat University | N/A |
US Patents and Regulatory Information for AMIKIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | AMIKIN | amikacin sulfate | INJECTABLE;INJECTION | 062311-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | amikacin sulfate | INJECTABLE;INJECTION | 050618-002 | Nov 30, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | AMIKIN | amikacin sulfate | INJECTABLE;INJECTION | 062311-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
